[{"quiz_id": "20251205T080918850Z_kimi-k2-thinking_seed125", "question_id": "20251205T080918850Z_kimi-k2-thinking_seed125-001", "question": "A 45-year-old with severe ARDS on VV-ECMO develops suspected heparin-induced thrombocytopenia (4T score 6). Heparin is discontinued and argatroban initiated. The patient has significant hemolysis (plasma free hemoglobin 800 mg/dL). Which monitoring assay is most reliable for titrating argatroban in this setting?", "options": ["Activated partial thromboplastin time (aPTT)", "Anti-Xa chromogenic assay", "Anti-IIa (thrombin) chromogenic assay", "Activated clotting time (ACT)", "Dilute Russell viper venom time (dRVVT)"], "answer": "C", "answer_index": 2, "explanation": "Anti-IIa chromogenic assay directly measures thrombin inhibition by argatroban and is least affected by hemolysis, platelet count, or factor consumption seen in ECMO. aPTT is unreliable due to factor deficiency and hemolysis. Anti-Xa assays measure anti-Xa activity, not direct thrombin inhibitors. ACT is affected by platelets and fibrinogen. dRVVT is used for lupus anticoagulant detection.", "generator_model": "kimi-k2-thinking", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. The stem presents a specific scenario: severe ARDS on VV-ECMO with HIT on argatroban and significant hemolysis, asking for the most reliable monitoring assay. The key discriminating findings are the use of a direct thrombin inhibitor (argatroban) and the presence of hemolysis, which can interfere with clot-based assays like aPTT and ACT. The anti-IIa chromogenic assay directly measures thrombin inhibition and is known to be less affected by hemolysis and other confounders present in ECMO/critical illness, making it the most reliable. The keyed answer (C) aligns with this logic. Alternatives are correctly inferior: aPTT (A) and ACT (D) are affected by hemolysis and factor deficiencies; anti-Xa (B) does not measure direct thrombin inhibitors; dRVVT (E) is for lupus anticoagulant. No contradictions or missing critical details exist. Medical accuracy is sound. Minimal fix: None required for logical validity; to enhance clarity, the stem could explicitly state 'clot-based assays like aPTT are unreliable due to hemolysis.'\",\n    \"logical_false_reason\": \"T\",\n    \"logical_validity\": true,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 1204)"}, {"quiz_id": "20251205T080918850Z_kimi-k2-thinking_seed125", "question_id": "20251205T080918850Z_kimi-k2-thinking_seed125-002", "question": "A 62-year-old with metastatic pancreatic adenocarcinoma on gemcitabine presents with acute kidney injury (creatinine 3.2 mg/dL), platelet count 45,000/µL, schistocytes, LDH 2200 IU/L, and haptoglobin <10 mg/dL. ADAMTS13 activity is 35%. What is the most appropriate initial management?", "options": ["Urgent plasma exchange", "Eculizumab therapy", "Discontinue gemcitabine and provide supportive care", "Rituximab 375 mg/m² weekly", "Caplacizumab 10 mg daily"], "answer": "C", "answer_index": 2, "explanation": "Gemcitabine-induced thrombotic microangiopathy is a drug-mediated toxicity, not complement-mediated or immune-mediated. ADAMTS13 is not severely deficient (<10%), excluding TTP. Plasma exchange is ineffective. Eculizumab and caplacizumab are reserved for complement-mediated aHUS. Rituximab is for TTP. The cornerstone of management is immediate discontinuation of gemcitabine.", "generator_model": "kimi-k2-thinking", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: K. Verdict on keyed answer: Miskeyed. Key stem clues: Acute kidney injury, thrombocytopenia, schistocytes, elevated LDH, low haptoglobin, and ADAMTS13 activity of 35% define a thrombotic microangiopathy (TMA) in a patient on gemcitabine. The ADAMTS13 level >10% argues against typical immune-mediated TTP, making drug-induced TMA (DITMA) likely. Main logical issue: The key (C) is not the single best answer. While discontinuing the offending drug is essential, the most appropriate initial management for a severe, life-threatening TMA syndrome is urgent plasma exchange (PLEX) to remove pathogenic factors and mitigate organ damage, even in DITMA, as it is a critical supportive intervention. This makes option A defensible as best. Main medical accuracy issue: The rationale incorrectly states PLEX is ineffective in gemcitabine-induced TMA; guidelines support its use in severe cases. Minimal fix: Change the key to A (Urgent plasma exchange) and adjust the rationale to reflect that PLEX is indicated for severe TMA while discontinuing gemcitabine.\",\n    \"logical_false_reason\": \"K\",\n    \"logical_validity\": false,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 1184)"}, {"quiz_id": "20251205T080918850Z_kimi-k2-thinking_seed125", "question_id": "20251205T080918850Z_kimi-k2-thinking_seed125-003", "question": "A 28-year-old presents 2 hours after ingesting barium carbonate with profuse vomiting, diarrhea, and profound muscle weakness. Serum potassium is 2.1 mEq/L with ST-segment depression on ECG. What is the primary mechanism of hypokalemia and most effective elimination strategy?", "options": ["GI losses; emergent hemodialysis", "Intracellular shift via K+ channel blockade; oral sodium sulfate", "Renal tubular wasting; potassium-sparing diuretics", "Beta-agonist effect; beta-blockade therapy", "Insulin-mediated shift; IV insulin with glucose"], "answer": "B", "answer_index": 1, "explanation": "Barium blocks voltage-gated potassium channels (Kv), preventing cellular efflux and causing intracellular K+ sequestration. Hemodialysis is ineffective due to barium's large volume of distribution (1.5 L/kg). Oral sodium sulfate precipitates residual Ba2+ as insoluble BaSO4 in the GI tract if administered within 24 hours, preventing further absorption. Massive IV potassium replacement is necessary but does not address elimination.", "generator_model": "kimi-k2-thinking", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. The keyed answer (B) incorrectly identifies the primary mechanism as intracellular shift via K+ channel blockade, which is accurate, but the most effective elimination strategy is not oral sodium sulfate. The vignette describes presentation 2 hours post-ingestion with profuse vomiting and diarrhea, indicating significant absorption has already occurred. The most effective elimination strategy for severe, symptomatic barium poisoning with life-threatening hypokalemia is hemodialysis, which effectively removes absorbed barium. While oral sodium sulfate can bind residual unabsorbed barium, it is not the most effective strategy overall in this acute, systemic presentation. The item's logic is medically accurate regarding mechanism but misapplies the elimination strategy. Minimal fix: Change the key to A (GI losses; emergent hemodialysis) or revise option B's strategy to 'supportive care with IV potassium and consider hemodialysis' to align with toxicology guidelines.\",\n    \"logical_false_reason\": \"K\",\n    \"logical_validity\": false,\n    \"medical_accuracy_score\":  \"3\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. The keyed answer (B) incorrectly identifies the primary mechanism as intracellular shift via K+ channel blockade, which is accurate, but the most effective elimination strategy is not oral sodium sulfate. The vignette describes presentation 2 hours post-ingestion with profuse vomiting and diarrhea, indicating significant absorption has already occurred. The most effective elimination strategy for severe, symptomatic barium poisoning with life-threatening hypokalemia is hemodialysis, which effectively removes absorbed barium. While oral sodium sulfate can bind residual unabsorbed barium, it is not the most effective strategy overall in this acute, systemic presentation. The item's logic is medically accurate regarding mechanism but misapplies the elimination strategy. Minimal fix: Change the key to A (GI losses; emergent hemodialysis) or revise option B's strategy to 'supportive care with IV potassium and consider hemodialysis' to align with toxicology guidelines.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251205T080918850Z_kimi-k2-thinking_seed125", "question_id": "20251205T080918850Z_kimi-k2-thinking_seed125-004", "question": "A 3-month-old infant presents with intractable seizures, hypotonia, and developmental regression. Brain MRI shows bilateral globus pallidus hyperintensity. Plasma creatine level is low. Which test provides the most specific diagnosis for guanidinoacetate methyltransferase (GAMT) deficiency?", "options": ["Plasma guanidinoacetate measurement", "Urine creatine:creatinine ratio", "Cerebrospinal fluid guanidinoacetate level", "GAMT gene sequencing", "Brain magnetic resonance spectroscopy"], "answer": "C", "answer_index": 2, "explanation": "CSF guanidinoacetate is the most sensitive and specific biomarker for GAMT deficiency due to accumulation behind the blood-brain barrier. Plasma GAA can be normal in mild cases. Urine ratio is supportive but nonspecific. GAMT sequencing may miss deep intronic variants or large deletions. MRS shows absent creatine peak but does not identify the specific enzyme defect.", "generator_model": "kimi-k2-thinking", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K. Verdict on keyed answer: Miskeyed. The stem describes classic GAMT deficiency findings: infantile seizures, hypotonia, regression, bilateral globus pallidus hyperintensity, and low plasma creatine. The most specific diagnostic test for GAMT deficiency is GAMT gene sequencing (D), which confirms the genetic etiology. While CSF guanidinoacetate (C) is elevated and a useful biomarker, gene sequencing is the definitive gold standard. The keyed answer (C) is not the single best answer. The item is medically accurate but logically miskeyed. Minimal fix: Change the correct answer key to D (GAMT gene sequencing) to align with standard diagnostic confirmation.\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \t\n  \"4\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K. Verdict on keyed answer: Miskeyed. The stem describes classic GAMT deficiency findings: infantile seizures, hypotonia, regression, bilateral globus pallidus hyperintensity, and low plasma creatine. The most specific diagnostic test for GAMT deficiency is GAMT gene sequencing (D), which confirms the genetic etiology. While CSF guanidinoacetate (C) is elevated and a useful biomarker, gene sequencing is the definitive gold standard. The keyed answer (C) is not the single best answer. The item is medically accurate but logically miskeyed. Minimal fix: Change the correct answer key to D (GAMT gene sequencing) to align with standard diagnostic confirmation.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251205T080918850Z_kimi-k2-thinking_seed125", "question_id": "20251205T080918850Z_kimi-k2-thinking_seed125-005", "question": "A 58-year-old develops progressive non-REM parasomnia, obstructive sleep apnea, bulbar dysfunction, and gait ataxia over 18 months. CSF shows mild lymphocytic pleocytosis. Which antibody and pathological finding are most characteristic?", "options": ["Anti-Hu; neuronal nuclear inclusions", "Anti-NMDA receptor; perivascular lymphocytic cuffing", "Anti-IgLON5; tau deposition in brainstem and hypothalamus", "Anti-LGI1; faciobrachial dystonic seizures", "Anti-GAD65; cerebellar Purkinje cell loss"], "answer": "C", "answer_index": 2, "explanation": "Anti-IgLON5 disease presents with sleep dysfunction (non-REM parasomnia, obstructive apnea) and bulbar symptoms, distinct from other autoimmune encephalitides. Unlike typical antibody-mediated diseases, it is characterized by tauopathy (4R-tau deposition) in the brainstem and hypothalamus on autopsy, correlating with poor response to immunotherapy. Anti-Hu is associated with small cell lung cancer and sensory neuropathy. Anti-LGI1 presents with faciobrachial dystonic seizures and hyponatremia.", "generator_model": "kimi-k2-thinking", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: progressive non-REM parasomnia, obstructive sleep apnea, bulbar dysfunction, gait ataxia, and CSF lymphocytic pleocytosis over 18 months. This constellation is highly specific for anti-IgLON5 disease, a distinct autoimmune/neurodegenerative disorder. The keyed answer (C) correctly pairs the anti-IgLON5 antibody with tau deposition in the brainstem/hypothalamus, which is its characteristic neuropathology. Alternatives are incorrect: Anti-Hu (A) is paraneoplastic with sensory neuropathy; Anti-NMDA (B) presents with psychiatric features and seizures; Anti-LGI1 (D) presents with faciobrachial dystonic seizures; Anti-GAD65 (E) is linked to stiff-person syndrome and cerebellar ataxia but not this specific sleep/bulbar syndrome. No logical contradictions or missing details. Medical accuracy is high. Minimal fix: None required; the item is well-constructed.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\":  \t\n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. Key stem clues: progressive non-REM parasomnia, obstructive sleep apnea, bulbar dysfunction, gait ataxia, and CSF lymphocytic pleocytosis over 18 months. This constellation is highly specific for anti-IgLON5 disease, a distinct autoimmune/neurodegenerative disorder. The keyed answer (C) correctly pairs the anti-IgLON5 antibody with tau deposition in the brainstem/hypothalamus, which is its characteristic neuropathology. Alternatives are incorrect: Anti-Hu (A) is paraneoplastic with sensory neuropathy; Anti-NMDA (B) presents with psychiatric features and seizures; Anti-LGI1 (D) presents with faciobrachial dystonic seizures; Anti-GAD65 (E) is linked to stiff-person syndrome and cerebellar ataxia but not this specific sleep/bulbar syndrome. No logical contradictions or missing details. Medical accuracy is high. Minimal fix: None required; the item is well-constructed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T080918850Z_kimi-k2-thinking_seed125", "question_id": "20251205T080918850Z_kimi-k2-thinking_seed125-006", "question": "During VV-ECMO for severe ARDS, the circuit suddenly shows extensive air with the patient becoming pulseless. What is the immediate management step?", "options": ["Place patient in left lateral decubitus and Trendelenburg position while continuing pump", "Clamp venous line, stop pump, aspirate from arterial port", "Increase ECMO flow to 6 L/min to clear air emboli", "Administer 100% oxygen and initiate CPR", "Convert circuit to VA-ECMO configuration"], "answer": "B", "answer_index": 1, "explanation": "In VV-ECMO, air embolism is venous. The immediate action is to stop the pump to halt further embolization, clamp the venous line to prevent additional air entry, and aspirate air from the arterial (outflow) line port. Durant's position is ineffective for venous emboli. Increasing pump flow worsens embolization. CPR is secondary to circuit management. Configuration change does not address the acute air emergency.", "generator_model": "kimi-k2-thinking", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: VV-ECMO circuit, sudden extensive air, patient pulseless. This describes a massive air embolism, a life-threatening circuit emergency. The immediate priority is to stop the source of air and prevent it from reaching the patient. Option B correctly outlines the standard emergency drill: clamp venous line (prevent more air), stop pump (halt embolization), aspirate from arterial port (remove air). Alternatives are incorrect: A (Durant's position) is for arterial air, not venous/ECMO; C (increase flow) worsens the problem; D (CPR) is secondary to securing the circuit; E (conversion) is not an immediate step. The item is logically valid and medically accurate. Minimal fix: None required; the item is clear and correct.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\":  \t\n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. Key stem clues: VV-ECMO circuit, sudden extensive air, patient pulseless. This describes a massive air embolism, a life-threatening circuit emergency. The immediate priority is to stop the source of air and prevent it from reaching the patient. Option B correctly outlines the standard emergency drill: clamp venous line (prevent more air), stop pump (halt embolization), aspirate from arterial port (remove air). Alternatives are incorrect: A (Durant's position) is for arterial air, not venous/ECMO; C (increase flow) worsens the problem; D (CPR) is secondary to securing the circuit; E (conversion) is not an immediate step. The item is logically valid and medically accurate. Minimal fix: None required; the item is clear and correct.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T080918850Z_kimi-k2-thinking_seed125", "question_id": "20251205T080918850Z_kimi-k2-thinking_seed125-007", "question": "A 22-year-old with relapsed ALL receives axicabtagene ciloleucel. On day 12, he develops status epilepticus and CT shows cerebral edema, unresponsive to methylprednisolone 1 g/day for 3 days. What is the most appropriate next therapy for steroid-refractory ICANS?", "options": ["Increase methylprednisolone to 2 g/day", "Anakinra 100 mg intravenously", "Tocilizumab 8 mg/kg intravenously", "Cyclophosphamide 500 mg/m²", "Therapeutic plasma exchange"], "answer": "B", "answer_index": 1, "explanation": "Anakinra, an IL-1 receptor antagonist, is the preferred therapy for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS). Tocilizumab targets IL-6 and is effective for cytokine release syndrome but has limited efficacy for ICANS. Escalating steroids beyond 1 g/day provides minimal additional benefit. Cyclophosphamide is not used for ICANS. Plasma exchange would eliminate the therapeutic CAR-T cells.", "generator_model": "kimi-k2-thinking", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: steroid-refractory ICANS (grade 4 neurotoxicity) after CAR-T therapy. The vignette clearly describes a severe, steroid-refractory case. The most appropriate next therapy, per current consensus guidelines (e.g., ASCO, SITC), is tocilizumab, not anakinra. Tocilizumab is the standard second-line agent for high-grade ICANS, with anakinra considered an alternative or later-line option. The keyed answer (B) is not the single best, guideline-supported choice. Main logical issue: a unique best answer exists (C), but the provided key is incorrect. Main medical accuracy issue: the rationale incorrectly downplays tocilizumab's role in ICANS. Minimal fix: Change the correct answer key to C (Tocilizumab) and update the explanation to reflect its guideline-supported use for steroid-refractory ICANS.\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \t\n  \"3\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: steroid-refractory ICANS (grade 4 neurotoxicity) after CAR-T therapy. The vignette clearly describes a severe, steroid-refractory case. The most appropriate next therapy, per current consensus guidelines (e.g., ASCO, SITC), is tocilizumab, not anakinra. Tocilizumab is the standard second-line agent for high-grade ICANS, with anakinra considered an alternative or later-line option. The keyed answer (B) is not the single best, guideline-supported choice. Main logical issue: a unique best answer exists (C), but the provided key is incorrect. Main medical accuracy issue: the rationale incorrectly downplays tocilizumab's role in ICANS. Minimal fix: Change the correct answer key to C (Tocilizumab) and update the explanation to reflect its guideline-supported use for steroid-refractory ICANS.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251205T080918850Z_kimi-k2-thinking_seed125", "question_id": "20251205T080918850Z_kimi-k2-thinking_seed125-008", "question": "A 35-year-old presents with refractory shock (BP 70/40) and bradycardia (HR 40) after ingesting 10 g of sustained-release verapamil. High-dose insulin euglycemic therapy (HIET) is initiated. What is the optimal insulin dosing and monitoring frequency?", "options": ["0.5-1 unit/kg/hr; check glucose every 2 hours", "1-10 units/kg/hr; check glucose every hour", "0.1-0.5 units/kg/hr; check potassium every 4 hours", "5-20 units/kg/hr; check lactate every 2 hours", "2-5 units/kg/hr; check pH every 4 hours"], "answer": "B", "answer_index": 1, "explanation": "HIET for severe calcium channel blocker overdose requires supraphysiologic insulin doses of 1-10 units/kg/hr to overcome insulin resistance and maximize myocardial glucose uptake. Blood glucose must be monitored hourly to maintain euglycemia (150-200 mg/dL) with concurrent dextrose infusion. Lower doses are ineffective. Doses exceeding 10 units/kg/hr are not standard practice. Potassium and pH are monitored but glucose is the critical parameter.", "generator_model": "kimi-k2-thinking", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. The clinical problem is determining the optimal insulin dosing and glucose monitoring frequency for high-dose insulin euglycemic therapy (HIET) in severe verapamil overdose. Key stem clues are refractory shock and bradycardia, indicating a severe, life-threatening calcium channel blocker (CCB) overdose requiring aggressive HIET. The keyed answer (B) correctly states the critical glucose monitoring frequency (hourly) but incorrectly specifies an insulin dosing range of 1-10 units/kg/hr. The widely accepted, guideline-endorsed standard dosing for HIET in CCB overdose is 0.5-1 unit/kg/hr as an initial bolus followed by a 0.5-1 unit/kg/hr infusion. Option A correctly states this dosing (0.5-1 unit/kg/hr) and a reasonable glucose check frequency (every 2 hours, though hourly is also acceptable). Therefore, a unique best answer exists (A), but the provided key (B) is not it. The main logical issue is miskeying. The main medical accuracy issue is the incorrect high-dose range in the key. Minimal fix: Change the key to A and adjust the rationale to reflect standard dosing (0.5-1 unit/kg/hr) and note that glucose monitoring every 1-2 hours is appropriate.\",\n    \"logical_false_reason\": \"K\",\n    \"logical_validity\": false,\n    \"medical_accuracy_score\":  \"2\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. The clinical problem is determining the optimal insulin dosing and glucose monitoring frequency for high-dose insulin euglycemic therapy (HIET) in severe verapamil overdose. Key stem clues are refractory shock and bradycardia, indicating a severe, life-threatening calcium channel blocker (CCB) overdose requiring aggressive HIET. The keyed answer (B) correctly states the critical glucose monitoring frequency (hourly) but incorrectly specifies an insulin dosing range of 1-10 units/kg/hr. The widely accepted, guideline-endorsed standard dosing for HIET in CCB overdose is 0.5-1 unit/kg/hr as an initial bolus followed by a 0.5-1 unit/kg/hr infusion. Option A correctly states this dosing (0.5-1 unit/kg/hr) and a reasonable glucose check frequency (every 2 hours, though hourly is also acceptable). Therefore, a unique best answer exists (A), but the provided key (B) is not it. The main logical issue is miskeying. The main medical accuracy issue is the incorrect high-dose range in the key. Minimal fix: Change the key to A and adjust the rationale to reflect standard dosing (0.5-1 unit/kg/hr) and note that glucose monitoring every 1-2 hours is appropriate.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251205T080918850Z_kimi-k2-thinking_seed125", "question_id": "20251205T080918850Z_kimi-k2-thinking_seed125-009", "question": "A 6-month-old male infant presents with severe eczema, petechiae, recurrent otitis media, and platelet count of 30,000/µL with small platelet volume. What is the most sensitive diagnostic test for Wiskott-Aldrich syndrome?", "options": ["WASP gene sequencing", "Platelet-associated antibody testing", "Lymphocyte subset enumeration", "WASP protein expression by flow cytometry", "Serum IgE and IgA levels"], "answer": "D", "answer_index": 3, "explanation": "Flow cytometry for WASP protein expression in lymphocytes is more sensitive than standard gene sequencing, which may miss large deletions, splice site mutations, or deep intronic variants. Absent or reduced WASP protein expression confirms the diagnosis. Platelet antibodies are negative. Lymphocyte subsets are variable. IgE is elevated and IgA is low but these are nonspecific.", "generator_model": "kimi-k2-thinking", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. The question asks for the most sensitive diagnostic test for Wiskott-Aldrich syndrome (WAS) in an infant with classic features (eczema, thrombocytopenia with small platelets, recurrent infections). While WASP protein flow cytometry (option D) is a rapid and useful functional test, the most sensitive and definitive test is WASP gene sequencing (option A), which identifies the causative mutation and is considered the gold standard. The provided rationale incorrectly prioritizes sensitivity of flow cytometry over sequencing. The stem clues strongly point to WAS, making a unique best answer (gene sequencing) determinable, but the keyed answer is wrong. Minimal fix: Change the correct answer key to A (WASP gene sequencing).\",\n    \"logical_false_reason\": \"K\",\n    \"logical_validity\": false,\n    \"medical_accuracy_score\":  \"3\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. The question asks for the most sensitive diagnostic test for Wiskott-Aldrich syndrome (WAS) in an infant with classic features (eczema, thrombocytopenia with small platelets, recurrent infections). While WASP protein flow cytometry (option D) is a rapid and useful functional test, the most sensitive and definitive test is WASP gene sequencing (option A), which identifies the causative mutation and is considered the gold standard. The provided rationale incorrectly prioritizes sensitivity of flow cytometry over sequencing. The stem clues strongly point to WAS, making a unique best answer (gene sequencing) determinable, but the keyed answer is wrong. Minimal fix: Change the correct answer key to A (WASP gene sequencing).", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251205T080918850Z_kimi-k2-thinking_seed125", "question_id": "20251205T080918850Z_kimi-k2-thinking_seed125-010", "question": "A 28-year-old develops progressive myoclonus epilepsy, cerebellar ataxia, and visual loss over 3 years. EEG shows generalized spike-wave discharges. Which test is most specific for diagnosing Kufs disease (adult neuronal ceroid lipofuscinosis)?", "options": ["Epilepsy gene panel (SCN1A, GABRG2)", "Brain biopsy with periodic acid-Schiff staining", "Skin biopsy with electron microscopy", "CSF 14-3-3 protein immunoassay", "Serum anti-GAD65 antibody titer"], "answer": "C", "answer_index": 2, "explanation": "Electron microscopy of skin biopsy showing fingerprint profiles or granular osmiophilic deposits is the most specific diagnostic test for neuronal ceroid lipofuscinosis. Genetic testing (CLN6, CLN8, CTSF) is confirmatory but may be negative in variant forms. Brain biopsy is invasive and unnecessary. CSF 14-3-3 protein is elevated in Creutzfeldt-Jakob disease. Anti-GAD65 antibodies are associated with autoimmune epilepsy, not NCL.", "generator_model": "kimi-k2-thinking", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: adult-onset progressive myoclonus epilepsy, cerebellar ataxia, visual loss, and generalized spike-wave EEG, suggesting a neurodegenerative storage disorder like adult neuronal ceroid lipofuscinosis (Kufs disease). The most specific diagnostic test for NCL is electron microscopy of a skin or other tissue biopsy to identify characteristic ultrastructural inclusions (e.g., fingerprint profiles). The keyed answer (C) is correct. Alternative A (epilepsy gene panel) targets ion channel epilepsies, not NCL. B (brain biopsy) is invasive and less specific than skin biopsy. D (CSF 14-3-3) is for prion disease. E (anti-GAD65) is for autoimmune encephalitis. No logical contradictions or underspecification; a single best answer is supported. Medical accuracy is sound. Minimal fix: none required; item is valid and accurate.\",\n    \"logical_false_reason\": \"T\",\n    \"logical_validity\": true,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 1009)"}]